STOCK TITAN

Tessera to lift MEA stake to 15%, issue 195K shares

Tessera expands its stake and rights in MEA’s drone testing business via equity issuance, a convertible loan, and a broad royalty-free license.

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Tessera Defense & Homeland Security Inc. (HLSQ) amended its Share Purchase and Option Agreement with Mayers Ventures LLC to increase its planned initial stake in M.E.A. Testing Systems Ltd. from 10% to 15% of MEA’s share capital on a fully diluted basis, subject to listing approval.

The consideration now includes 195,000 Tessera common shares (130,000 issued at closing and 65,000 issuable upon NYSE American authorization), which equals about 4.5% of Tessera’s outstanding common stock. Tessera also established an unsecured up to $475,000 convertible loan to the seller at 12% interest, convertible into MEA shares based on MEA’s 2027 EBITDA or a $10,000,000 valuation, capped at 19.999% total MEA ownership.

Separately, MEA granted Tessera a perpetual, irrevocable, worldwide, fully paid-up and royalty-free license, exclusive for testing, validation and evaluation of unmanned aerial vehicles and propulsion systems and non-exclusive for other defense and security uses. Tessera closed the initial purchase of 324,573 MEA shares (10%) and issued 130,000 Tessera shares on September 16, 2026 under a private placement exemption.

Positive

  • Strategic 10–15% stake plus option in MEA’s drone and unmanned systems testing business, combined with a broad, perpetual, royalty-free license, strengthens Tessera’s access to specialized UAV testing technology.
  • Royalty-free, fully transferable license with exclusive rights for UAV testing and evaluation can support Tessera’s product development and potential sublicensing opportunities without ongoing cash royalties.

Negative

  • Share issuance of 195,000 shares, equal to about 4.5% of outstanding common stock, creates equity dilution for existing shareholders.

Filing Explained

The amendment did not exercise Tessera’s separate option to acquire Motomova’s remaining interest in MEA. That option remains exercisable through June 30, 2028 at a price based on MEA’s audited results for the year ending December 31, 2027; the option covers the interest remaining after the amended purchase.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Initial MEA stake purchased 324,573 MEA shares (10% fully diluted) Purchased and closed on September 16, 2026
Planned MEA stake after amendment 486,860 MEA shares (15% fully diluted) Subject to NYSE American authorization of additional Tessera shares
Tessera shares issued at closing 130,000 shares Issued to Mayers Ventures LLC on September 16, 2026 as consideration
Total Tessera shares under agreement 195,000 shares (about 4.5% of outstanding) Shares issuable to the seller under the amended agreement
Convertible loan facility $475,000 Unsecured facility to the seller at 12% interest, maturing two years after closing
Loan interest rate 12% per annum Applies to the unsecured loan facility, including the $50,000 advance
MEA valuation reference cap $10,000,000 Upper valuation used to set MEA share price for loan conversion
MEA ownership cap after conversion 19.999% fully diluted Maximum combined MEA stake from purchased shares and loan conversion
Share Purchase and Option Agreement financial
"entered into Amendment No. 1 (the “Amendment”) to the Share Purchase and Option Agreement"
fully diluted basis financial
"representing 10% of MEA’s share capital on a fully diluted basis"
A fully diluted basis counts every share that could exist if all outstanding options, warrants, convertible securities and other rights were exercised or converted into common stock, showing the maximum number of shares outstanding. For investors this matters because it spreads ownership and earnings across that larger share count, like slicing a pie into every possible piece before deciding how big each investor’s slice will be, which affects per-share value and ownership percentage.
convertible loan financial
"provides for the Company to make available to the Seller an unsecured loan facility"
A convertible loan is money lent to a company that can later be changed into shares instead of being repaid in cash. For investors it combines the safety of a loan—priority for repayment if things go wrong—with the potential upside of owning part of the company if its value rises; think of it as lending money that can be swapped for a slice of the company pie under pre-agreed terms. It matters because it affects returns and how much ownership existing shareholders will have.
reverse stock split financial
"as adjusted for the Company’s one-for-ten reverse stock split effective September 9, 2026"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
perpetual, irrevocable, worldwide, fully paid-up and royalty-free license technical
"MEA granted to the Company a perpetual, irrevocable, worldwide, fully paid-up and royalty-free license"
Section 4(a)(2) of the Securities Act of 1933 regulatory
"in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did Tessera Defense & Homeland Security Inc. (HLSQ) announce with MEA?

Tessera entered an amendment to acquire up to 15% of M.E.A. Testing Systems Ltd. on a fully diluted basis, closed an initial purchase of 10%, and received a broad, perpetual, royalty-free technology license focused on unmanned aerial vehicle testing.

How many Tessera (HLSQ) shares are being issued in the MEA transaction?

Tessera is issuing a total of 195,000 common shares to the seller: 130,000 shares were issued at closing on September 16, 2026, and an additional 65,000 shares will be issued after NYSE American authorizes listing of those shares.

What percentage of Tessera’s stock does the MEA deal represent?

The 195,000 Tessera common shares issuable under the amended agreement represent approximately 4.5% of Tessera’s outstanding common stock as of September 16, 2026, resulting in equity dilution at that level for existing shareholders.

What technology license did Tessera (HLSQ) obtain from MEA?

MEA granted Tessera a perpetual, irrevocable, worldwide, fully paid-up and royalty-free license, exclusive for testing, validation and evaluation of unmanned aerial vehicles and their propulsion systems and non-exclusive for other defense, security and homeland security uses, with full sublicensing and transfer rights.

What option does Tessera have to increase its stake in MEA beyond 15%?

Tessera retains an option to acquire Motomova Inc.’s remaining MEA interest, exercisable through June 30, 2028 at a price based on MEA’s audited results for the fiscal year ending December 31, 2027, separate from the initial 10–15% purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001739174 0001739174 2026-09-16 2026-09-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 16, 2026

 

TESSERA DEFENSE AND HOMELAND SECURITY INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38762   82-3364020
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

850 New Burton Road, Suite 201

Dover, Delaware 19904

(Address of principal executive offices, including zip code)

 

(972) 52-437-4900

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   HLSQ   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On September 16, 2026, Tessera Defense and Homeland Security Inc. (the “Company”) entered into Amendment No. 1 (the “Amendment”) to the Share Purchase and Option Agreement dated August 5, 2026 (the “Agreement”) between the Company and Mayers Ventures LLC (the “Seller”). The Agreement, as previously reported in the Company’s Current Report on Form 8-K filed August 11, 2026, provides for the purchase by the Company of an equity interest in M.E.A. Testing Systems Ltd., an Israeli company that develops testing systems for drones and unmanned systems (“MEA”), and for the grant to the Company of an option to acquire the remaining interest in MEA held by Motomova Inc. (“Motomova”), MEA’s majority shareholder. On the same date, the Company also entered into a Technology License Agreement (the “License Agreement”) with MEA, and completed the closing of the purchase of the initial 10% interest in MEA provided for in the Agreement, each as described below.

 

Increase in the Purchased Interest. The Amendment increases the interest to be acquired by the Company at the closing under the Agreement from 324,573 shares of MEA, representing 10% of MEA’s share capital on a fully diluted basis, to 486,860 shares, representing 15% of MEA’s share capital on a fully diluted basis.

 

Consideration. The Amendment amends the consideration payable by the Company to consist of (i) 130,000 shares of the Company’s common stock issuable at the closing, being the 1,300,000 shares provided for in the Agreement as adjusted for the Company’s one-for-ten reverse stock split effective September 9, 2026, and (ii) an additional 65,000 shares of common stock issuable at the closing as consideration for the increase in the purchased interest, subject to authorization by the NYSE American of the listing of those shares. The cash payment of $50,000 provided for in the Agreement is replaced by an advance of $50,000 under the loan described below, to be applied by the Seller to amounts owed to the noteholders of Motomova. That advance is made as a loan, bears interest and is repayable in accordance with its terms, and does not constitute consideration for the purchased interest. The 195,000 shares issuable under the Agreement, as amended, represent approximately 4.5% of the Company’s outstanding common stock as of the date hereof.

 

Convertible Loan. The Amendment provides for the Company to make available to the Seller an unsecured loan facility of up to $475,000, bearing interest at 12% per annum, inclusive of the $50,000 advance described above, to be advanced in one or more tranches at the Seller’s request. The Company has no obligation to advance any amount before the closing. The loan matures on the second anniversary of the closing. The Seller is required to apply the proceeds to amounts owed to the noteholders of Motomova, to the working capital of MEA and to MEA’s drone-related activities, in each case by way of advances by the Seller to Motomova or MEA. At any time before repayment, the Company may elect to convert the outstanding principal and accrued interest into ordinary shares of MEA at a price per share determined by reference to the lower of a multiple of MEA’s EBITDA for the fiscal year ending December 31, 2027 and a valuation of $10,000,000. No conversion may result in the Company holding, together with the shares purchased at the closing, 19.999% or more of MEA’s share capital on a fully diluted basis. Any portion of the loan that cannot be converted without exceeding that limit remains outstanding as a non-convertible loan bearing interest at the same rate and is repaid at maturity.

 

Other Terms. The option granted to the Company under the Agreement to acquire Motomova’s remaining interest in MEA, exercisable through June 30, 2028 at a price based on MEA’s audited results for the fiscal year ending December 31, 2027, is unchanged, except that the shares subject to the option are Motomova’s holdings in MEA remaining after the transfer of the increased purchased interest. The Amendment is an amendment of the purchase provided for in the Agreement and is not an exercise, in whole or in part, of that option. The conditions to closing under the Agreement, including the entry into a license agreement between the Company and MEA and the authorization by the NYSE American of the listing of the shares to be issued, are unchanged.

 

1

 

 

License Agreement. Under the License Agreement, MEA granted to the Company a perpetual, irrevocable, worldwide, fully paid-up and royalty-free license, with the right to sublicense, under their patents, know-how and improvements, including their inertial dynamometer and regenerative dynamometer technologies and MEA’s drone testing solutions. The license is exclusive with respect to the testing, validation and evaluation of unmanned aerial vehicles and systems and their propulsion systems and components, and non-exclusive with respect to other defense, security and homeland security applications. Where an application falls within both, the license is exclusive. The license does not extend to the licensors’ other fields of use, including automotive and industrial motor testing. The license is fully transferable by the Company without the licensors’ consent. No separate royalty or license fee is payable by the Company, the license having been granted as part of the consideration under the Agreement. The Company has accepted the License Agreement in satisfaction of the closing condition in the Agreement relating to the grant of a technology license. The License Agreement is governed by the laws of the State of Israel.

 

Closing of the Initial Purchase. On September 16, 2026, the Company completed the closing of the purchase of 324,573 shares of MEA, representing 10% of MEA’s share capital on a fully diluted basis, and issued 130,000 shares of its common stock to the Seller as consideration. The increase in the purchased interest from 10% to 15% provided for in the Amendment, and the issuance of the additional 65,000 shares of common stock, remain subject to authorization by the NYSE American of the listing of those shares.

 

The foregoing descriptions of the Amendment and the License Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of those agreements, copies of which are filed as Exhibits 10.1 and 10.2 to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The information set forth in Item 1.01 with respect to the shares of common stock issuable to the Seller under the Agreement, as amended, is incorporated into this Item 3.02 by reference. On September 16, 2026, in connection with the closing described in Item 1.01, the Company issued 130,000 shares of common stock to the Seller. The remaining 65,000 shares issuable under the Agreement, as amended, will be issued upon authorization by the NYSE American of the listing of those shares. All such shares were or will be issued in a transaction not involving a public offering in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and bear a restrictive legend. The shares will bear a restrictive legend. No underwriting discounts or commissions were or will be paid in connection with the issuance.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
10.1   Amendment No. 1 to Share Purchase and Option Agreement, dated September 16, 2026, between Tessera Defense and Homeland Security Inc. and Mayers Ventures LLC.
10.2   Technology License Agreement, dated September 16, 2026, between Tessera Defense and Homeland Security Inc. and M.E.A. Testing Systems Ltd.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TESSERA DEFENSE AND HOMELAND SECURITY INC.

 

Date: September 22, 2026  
     
By: /s/ Michael Oster  
Name:  Michael Oster  
Title: Chief Executive Officer  

 

3

 

Filing Exhibits & Attachments

5 documents

Keep reading